Literature DB >> 24956070

Glucose variability indices in type 1 diabetes: parsimonious set of indices revealed by sparse principal component analysis.

Chiara Fabris1, Andrea Facchinetti, Giovanni Sparacino, Mattia Zanon, Stefania Guerra, Alberto Maran, Claudio Cobelli.   

Abstract

BACKGROUND: Continuous glucose monitoring (CGM) time-series are often analyzed, retrospectively, to investigate glucose variability (GV), a risk factor for the development of complications in type 1 diabetes (T1D). In the literature, several tens of different indices for GV quantification have been proposed, but many of them carry very similar information. The aim of this article is to select a relatively small subset of GV indices from a wider pool of metrics, to obtain a parsimonious but still comprehensive description of GV in T1D datasets.
MATERIALS AND METHODS: A pool of 25 GV indices was evaluated on two CGM time-series datasets of 17 and 16 T1D subjects, respectively, collected during the European Union Seventh Framework Programme project "Diadvisor" (2008-2012) in two different clinical research centers using the Dexcom(®) (San Diego, CA) SEVEN(®) Plus. After the indices were centered and scaled, the Sparse Principal Component Analysis (SPCA) technique was used to determine a reduced set of metrics that allows preserving a high percentage of the variance of the whole original set. In order to assess whether or not the selected subset of GV indices is dataset-dependent, the analysis was applied to both datasets, as well as to the one obtained by merging them.
RESULTS: SPCA revealed that a subset of up to 10 different GV indices can be sufficient to preserve more than the 60% of the variance originally explained by all the 25 variables. It is remarkable that four of these GV indices (i.e., Index of Glycemic Control, percentage of Glycemic Risk Assessment Diabetes Equation score due to euglycemia, percentage Coefficient of Variation, and Low Blood Glucose Index) were selected for all the considered T1D datasets.
CONCLUSIONS: The SPCA methodology appears a suitable candidate to identify, among the large number of literature GV indices, subsets that allow obtaining a parsimonious, but still comprehensive, description of GV.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24956070     DOI: 10.1089/dia.2013.0252

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  16 in total

1.  Simple Linear Support Vector Machine Classifier Can Distinguish Impaired Glucose Tolerance Versus Type 2 Diabetes Using a Reduced Set of CGM-Based Glycemic Variability Indices.

Authors:  Enrico Longato; Giada Acciaroli; Andrea Facchinetti; Alberto Maran; Giovanni Sparacino
Journal:  J Diabetes Sci Technol       Date:  2019-03-31

2.  Assessment of Glucose Control Metrics by Discriminant Ratio.

Authors:  Vanessa Moscardó; Pau Herrero; Monika Reddy; Nathan R Hill; Pantelis Georgiou; Nick Oliver
Journal:  Diabetes Technol Ther       Date:  2020-10       Impact factor: 6.118

3.  Diabetes and Prediabetes Classification Using Glycemic Variability Indices From Continuous Glucose Monitoring Data.

Authors:  Giada Acciaroli; Giovanni Sparacino; Liisa Hakaste; Andrea Facchinetti; Giorgio Maria Di Nunzio; Alessandro Palombit; Tiinamaija Tuomi; Rafael Gabriel; Jaime Aranda; Saturio Vega; Claudio Cobelli
Journal:  J Diabetes Sci Technol       Date:  2017-06-01

Review 4.  Glucose variability, HbA1c and microvascular complications.

Authors:  Jan Škrha; Jan Šoupal; Jan Škrha; Martin Prázný
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

5.  Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes.

Authors:  Boris Kovatchev; Claudio Cobelli
Journal:  Diabetes Care       Date:  2016-04       Impact factor: 19.112

6.  Parsimonious Description of Glucose Variability in Type 2 Diabetes by Sparse Principal Component Analysis.

Authors:  Chiara Fabris; Andrea Facchinetti; Giuseppe Fico; Francesco Sambo; Maria Teresa Arredondo; Claudio Cobelli
Journal:  J Diabetes Sci Technol       Date:  2015-07-31

7.  Accuracy of Continuous Glucose Monitoring Measurements in Normo-Glycemic Individuals.

Authors:  Abimbola A Akintola; Raymond Noordam; Steffy W Jansen; Anton J de Craen; Bart E Ballieux; Christa M Cobbaert; Simon P Mooijaart; Hanno Pijl; Rudi G Westendorp; Diana van Heemst
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

8.  Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies.

Authors:  Petra Augstein; Peter Heinke; Lutz Vogt; Roberto Vogt; Christine Rackow; Klaus-Dieter Kohnert; Eckhard Salzsieder
Journal:  BMC Endocr Disord       Date:  2015-05-01       Impact factor: 2.763

9.  Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values.

Authors:  Feng-Fei Li; Bing-Li Liu; Reng-Na Yan; Hong-Hong Zhu; Pei-Hua Zhou; Hui-Qin Li; Xiao-Fei Su; Jin-Dan Wu; Dan-Feng Zhang; Lei Ye; Jian-Hua Ma
Journal:  Sci Rep       Date:  2017-05-08       Impact factor: 4.379

10.  Principal Component Analysis and Risk Factors for Acute Mountain Sickness upon Acute Exposure at 3700 m.

Authors:  Shi-Zhu Bian; Jun Jin; Ji-Hang Zhang; Qian-Ning Li; Jie Yu; Shi-Yong Yu; Jian-Fei Chen; Xue-Jun Yu; Jun Qin; Lan Huang
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.